Artelon Graft: A Game-Changer for Anterior Tibial Tendon Repair?
"Discover how this innovative polyurethane urea-based graft is revolutionizing the treatment of anterior tibial tendon ruptures, offering new hope for athletes and active individuals."
Anterior tibial tendon ruptures, while not the most common injuries, can be particularly debilitating, especially for athletes and active individuals over 40. These ruptures often lead to significant pain and limited mobility, impacting daily life and athletic performance. Delayed diagnosis is common, which can further complicate the recovery process.
Traditional treatments for anterior tibial tendon ruptures often involve autografts (using the patient's own tissue) or allografts (using donor tissue). However, these methods have limitations, including donor site morbidity, risk of rejection, and prolonged recovery times. The need for alternative solutions that promote faster healing and reduce complications has driven research and innovation in the field.
This article explores the use of a polycaprolactone-based polyurethane urea (PUUR) hyperelastic polymer, known as Artelon, in the repair and reconstruction of anterior tibial tendon ruptures. We'll delve into the science behind Artelon, its benefits, and how it's changing the landscape of tendon repair, offering a promising alternative for patients seeking a return to full function.
Clinical Impact
Anterior tibial tendon rupture can impair ankle function and everyday mobility. The extent of disability may depend on factors such as rupture chronicity, tendon elongation, and functional insufficiency. Because available evidence varies by patient and repair technique, the overall impact of Artelon augmentation remains an area for continued clinical evaluation.
Established Repair Strategies
Treatment for anterior tibial tendon rupture generally focuses on restoring tendon continuity and improving ankle function. Chronic or neglected ruptures may be more difficult to manage because tissue changes can include elongation and structural insufficiency. The benefits and limitations of reinforcement materials therefore require assessment in the context of the individual injury.
Evolution of Tendon Repair
Anterior tibial tendon repair has developed from conventional reconstruction toward techniques that may incorporate synthetic reinforcement. Artelon represents one example of this broader movement toward scaffold-based soft-tissue repair. Its role in anterior tibial tendon surgery remains an evolving part of the field.
Artelon: A New Approach to Tendon Repair
Artelon is a knitted textile matrix crafted from fibers of polycaprolactone-based polyurethane urea (PUUR). This unique material boasts hyperelastic and creep-resistant properties, making it an ideal candidate for tendon repair. But what sets Artelon apart from traditional methods?
- Biocompatibility: Artelon integrates without immune reaction.
- Mechanical Strength: Resembles natural tendons and ligaments.
- Controlled Degradation: Degrades benignly, transferring load to the healing tendon over time.
Recent Artelon Evidence
Recent reports describe Artelon as a FlexBand polyurethane-urea and polycaprolactone scaffold used to augment a tibialis anterior tendon allograft during revision anterior cruciate ligament reconstruction. A separate case report involved an 81-year-old man with a two-year-old neglected left tibialis anterior tendon rupture at the ankle, with hypertrophic callus formation, tendon elongation, and functional insufficiency. Stryker describes Artelon as a soft-tissue reinforcement solution for tendon and ligament applications. These reports support clinical interest in Artelon but represent case-based and product-level evidence rather than definitive proof of superiority.
Evidence Limitations
The available reports do not establish that Artelon is superior to all alternative reconstruction methods. One 2018 report found no complications in its use for anterior tibial tendon repair or reconstruction, with improved six-month outcomes and range of motion and strength similar to the uninjured side. However, the revision ACL literature itself describes a paucity of outcome evidence, and the cited findings come from limited clinical reports. Artelon FlexBand is designed to reinforce soft tissue, support connective-tissue ingrowth, mimic normal tissue elasticity, and provide load sharing, but these design goals should not be treated as proof of clinical success in every patient.
Comparing Repair Options
Artelon can be viewed as a reinforcement option rather than a universally established replacement for standard tendon reconstruction. Its proposed advantages include scaffold support, tissue ingrowth, elasticity intended to resemble normal tissue, and load sharing. Direct comparisons with other repair methods cannot be made confidently from the limited source material, so conclusions about relative effectiveness should remain cautious.
The Future of Tendon Repair is Here
The results of the study are encouraging. There were no complications reported with the use of the Artelon graft to augment anterior tibial tendon reconstruction and repair. Moreover, patient outcomes at 6 months showed significant improvement compared to preoperative levels. The range of motion and strength were similar to the contralateral, uninjured side, indicating a successful recovery.
Current Clinical Synthesis
The current evidence positions Artelon as a scaffold used to augment tendon tissue rather than as an independently proven cure for anterior tibial tendon rupture. In revision ACL reconstruction, investigators retrospectively reviewed Artelon augmentation of a tibialis anterior tendon allograft using a FlexBand polyurethane-urea and polycaprolactone scaffold. This application suggests potential value when additional reinforcement is desired, but the retrospective design limits broad conclusions. Clinical judgment remains necessary when translating this technique to anterior tibial tendon repair.
Expanding Applications
Future research may examine whether Artelon can be used consistently as a bio-scaffold for tendon allografts in more patients and settings. A June 20, 2025 report described two patient cases using Artelon with a tibialis anterior tendon allograft during revision ACL reconstruction, with one surgeon performing the technique in both cases. Artelon also presents its FLEXBAND innovations as tools for tendon and ligament injuries, including instability in sprained ankles and other joints. Larger comparative studies will be needed to determine how broadly these applications should be adopted.
Underlying Causes and Materials
A 2026 report on chronic tibialis anterior tendon rupture identified the anterior watershed zone as the presumed substrate for degenerative failure when commonly implicated systemic and pharmacologic factors were absent. This observation underscores that tendon rupture may involve local tissue vulnerability rather than only an acute mechanical event. Separately, Artelon has been reported as a polycaprolactone-based polyurethane-urea hyperelastic polymer used for anterior tibial tendon repair or reconstruction. These factors highlight the need to consider both the underlying tendon environment and the properties of any reinforcement material.
Patient-Centered Outcomes
For patients, the practical goals of anterior tibial tendon repair include restoring ankle function, strength, and mobility. Artelon may be considered when a surgeon believes additional soft-tissue reinforcement could support reconstruction, but individual outcomes can vary with injury chronicity and tissue condition. Decisions should therefore balance the available clinical evidence with the patient's functional needs and the characteristics of the rupture.
Artelon represents a safe and effective soft tissue augmentation device that can be used in the setting of anterior tibial tendon repair or reconstruction. Its unique properties and promising clinical outcomes make it a valuable tool for orthopedic surgeons seeking to improve patient outcomes and accelerate recovery.
As research continues and clinical experience grows, Artelon is poised to become a standard of care for anterior tibial tendon ruptures and other soft tissue injuries. This innovative graft offers a new lease on life for athletes and active individuals, helping them regain their mobility and return to the activities they love.